SMS Pharmaceuticals Ltd

smspharma.com BSE: 532815 NSE : SMSPHARMA
About [ edit ]

SMS Pharmaceuticals is a global player in API manufacturing industry. The company's products include Anti-Ulcer, Anti-fungal, Anti-migraine, Anti- Hypertensive,etc.

Website BSE NSE
  • Market Cap ₹ 1,217 Cr.
  • Current Price ₹ 144
  • High / Low ₹ 160 / 33.0
  • Stock P/E 26.6
  • Book Value ₹ 43.2
  • Dividend Yield 0.17 %
  • ROCE 13.0 %
  • ROE 9.43 %
  • Face Value ₹ 1.00
Edit ratios

Pros

Cons

  • Company has a low return on equity of 11.39% for last 3 years.
  • Dividend payout has been low at 6.22% of profits over last 3 years
  • Debtor days have increased from 27.56 to 43.21 days.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2008 Jun 2018 Sep 2018 Dec 2018 Mar 2019 Jun 2019 Sep 2019 Dec 2019 Mar 2020 Jun 2020 Sep 2020 Dec 2020
57 125 135 101 104 117 118 80 96 113 130 149
47 101 110 76 88 94 96 60 82 91 106 114
Operating Profit 11 24 25 26 16 23 22 20 14 21 24 34
OPM % 19% 19% 19% 25% 15% 20% 19% 25% 15% 19% 18% 23%
Other Income 1 0 1 1 1 1 1 1 3 1 1 1
Interest 2 3 3 3 3 3 3 3 3 3 3 3
Depreciation 1 5 5 5 5 5 5 5 6 5 6 6
Profit before tax 9 16 19 19 8 15 14 12 9 14 16 27
Tax % -16% 38% 34% 35% 22% 38% 34% 40% 28% 33% 31% 31%
Net Profit 10 7 10 9 13 8 10 8 6 7 11 21
EPS in Rs 1.02 0.85 1.19 1.11 1.57 0.92 1.17 0.90 0.75 0.83 1.30 2.53
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2007 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 TTM
193 611 438 463 465 412 488
145 522 363 369 375 332 394
Operating Profit 47 89 75 93 90 80 94
OPM % 25% 15% 17% 20% 19% 19% 19%
Other Income 5 4 1 2 3 5 6
Interest 8 17 16 15 12 12 11
Depreciation 5 19 19 20 19 22 23
Profit before tax 40 56 42 60 62 51 65
Tax % 36% 26% 14% 33% 34% 36%
Net Profit 25 41 28 32 40 32 46
EPS in Rs 2.55 4.83 3.36 3.75 4.73 3.73 5.41
Dividend Payout % 8% 4% 6% 7% 5% 7%
Compounded Sales Growth
10 Years:%
5 Years:%
3 Years:-2%
TTM:17%
Compounded Profit Growth
10 Years:%
5 Years:%
3 Years:4%
TTM:19%
Stock Price CAGR
10 Years:24%
5 Years:14%
3 Years:22%
1 Year:327%
Return on Equity
10 Years:%
5 Years:%
3 Years:11%
Last Year:9%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Corporate actions
Mar 2007 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Sep 2020
10 8 8 8 8 8 8
Reserves 182 285 246 276 313 340 358
Borrowings 73 204 149 146 144 157 145
64 158 89 72 93 103 179
Total Liabilities 329 656 493 503 559 608 690
69 370 290 279 281 280 271
CWIP 15 13 8 8 18 42 99
Investments 0 21 29 28 27 26 23
245 252 166 187 232 259 297
Total Assets 329 656 493 503 559 608 690

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2007 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
14 61 73 32 50 40
-32 -97 -39 -17 -35 -43
107 27 -33 -15 -13 -2
Net Cash Flow 89 -9 1 0 2 -5

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2007 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
ROCE % 13% 18% 17% 13%
Debtor Days 114 36 18 19 20 43
Inventory Turnover 3.06 3.12 2.58 2.00

Shareholding Pattern

Numbers in percentages

Mar 2018 Jun 2018 Sep 2018 Dec 2018 Mar 2019 Jun 2019 Sep 2019 Dec 2019 Mar 2020 Jun 2020 Sep 2020 Dec 2020
67.27 67.27 67.27 67.27 67.27 67.27 67.29 67.29 67.29 67.29 67.29 67.29
0.01 0.01 0.00 0.00 0.00 0.00 0.53 0.53 0.53 0.53 0.30 0.56
0.19 0.15 0.02 0.02 0.04 0.03 0.02 0.02 0.00 0.00 0.00 0.00
32.53 32.57 32.71 32.71 32.69 32.70 32.15 32.16 32.17 32.17 32.41 32.15

Documents

Recent announcements


View all

Annual reports

Credit ratings